Name Net increased
positions
Increased positions Reduced positions Return since
30 Jun ‘16
51
13 69 56 71.1%
52
13 23 10 42.1%
53
13 35 22 43.4%
KPTI icon
54
Karyopharm Therapeutics
KPTI
$103M
13 31 18 93.6%
55
13 28 15 30.1%
56
12 30 18 68.9%
57
12 57 45 48.6%
58
12 33 21 20.1%
59
12 41 29 7.06%
60
12 21 9 19.2%
ESCA icon
61
Escalade
ESCA
$162M
12 22 10 14.9%
62
12 39 27 62.8%
63
11 23 12 46.9%
64
11 12 1 14.2%
65
11 21 10 18.5%
66
11 15 4 46.5%
67
11 16 5 96.7%
68
11 19 8 56.3%
69
11 21 10 10.2%
70
11 23 12 99.7%
71
11 46 35 61.5%
72
11 15 4 60.7%
73
11 15 4 65.5%
74
11 75 64 98.9%
75
11 48 37 67.4%